Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/5/2025 | $5.00 | Buy | H.C. Wainwright |
| 8/22/2024 | $9.00 | Buy | Rodman & Renshaw |
| 6/20/2023 | $8.00 → $4.00 | Buy → Hold | Jefferies |
| 4/22/2022 | $8.00 → $10.00 | Neutral → Overweight | Piper Sandler |
H.C. Wainwright resumed coverage of Milestone Pharmaceuticals with a rating of Buy and set a new price target of $5.00
Rodman & Renshaw initiated coverage of Milestone Pharmaceuticals with a rating of Buy and set a new price target of $9.00
Jefferies downgraded Milestone Pharmaceuticals from Buy to Hold and set a new price target of $4.00 from $8.00 previously